This morning I read a tweet from a friend which contained this article:
How convenient. From the (Corporate US owned) CDC website: https://www.cdc.gov/smallpox/clinicians/vaccines.html
Imvamune (MVA-BN) is a replication-deficient smallpox vaccine currently under development and seeking FDA approval. Unlike ACAM2000® and APSV, Imvamune is an attenuated live virus vaccine.
As a replication-deficient vaccine, it would be recommended for persons with certain immune deficiencies or conditions. Should a smallpox emergency occur, Imvamune would be made available for use under an EUA for persons of all ages with a diagnosis of HIV or atopic dermatitis during a post-event, pre-exposure setting. The specific clinical guidance on use of Imvamune in a smallpox emergency will be based on risk of exposure and relative contraindications to ACAM2000®.
Unlike ACAM2000® and APSV, Imvamune is administered subcutaneously as two doses separated by 4 weeks (one dose at week 0 and a second dose at week 4) for primary vaccinees (individuals who have never been vaccinated against smallpox or do not recall receiving a smallpox vaccination in the past). Individuals previously vaccinated against smallpox receive one dose.”
Smell a rat yet? There is more, a lot more.
Enter Dr. Suzanne Humphries, Dissolving smallpox illusions. Watch and listen. It may save your life, and those of your loved ones!
let the love light that we are dissolve the illusion of what we are not